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Summary
Mice homozygous for the gene lpr develop marked lymphadenopathy and a spectrum of
autoantibodies closely resembling that of human systemic lupus erythematosus. The unusual
T cell phenotype ofthe expanded lymphocyte population and theT -dependence of several antibodies
in this strain have suggested that primaryT cell abnormalities underlie the autoimmune syndrome.
Using double chimeras, we now show that expression of the lpr gene in B cells is absolutely
necessary for autoantibody production. Combinations of antiThy 1.2 + C' treated bonemarrow
from congenic strains ofC57BL/6 mice, differing only at the immunoglobulin heavy chain (Igh)
and lprloci, were transferred into lethally irradiated B6/lpr mice . Double chimerism was documented
by allotype-specific surface IgD and IgM immunofluorescence assay of peripheral blood and by
allotype-specific enzyme-linked immunosorbent assay for total IgM in serum . Despite the presence
ofboth +/+ and lprB cells, IgM and IgG2a anti-chromatin as well asIgM anti-IgG were entirely
the products oflprB cells. Total serum IgG2a and IgG1 were also dominated by the 1pr phenotype
but not to the same extent. A similar experiment using B6/lpr-Igh' recipients confirmed these
findings . Additional experiments in which B6/lpr recipients were infused with ratios of donor
bone marrow favoring B6.C20 +/+ over B6/lpr showed that even though +/+ B cells were
overrepresented, autoantibodies were only of the lpr allotype . In addition, in the presence of
lpr B cells, normal B cells showed little response to an exogenous, T cell-dependent antigen.
The data thus indicate that 1pr B cells manifest an intrinsic abnormality which is essential for
autoantibody production in the lpr model .
M
ice homozygous for the autosomal recessive gene lpr
develop a broad spectrum of autoantibodies and a clin-
ical syndrome resembling human SLE . One of the most
striking features of these mice is the marked accumulation
of abnormal lymphocytes in lymph nodes and, to a lesser
extent, in the spleen . The expanded population appears to
be of T cell lineage, since the cells bear T cell receptors (1,
2) and have a germline immunoglobulin gene configuration
(2) . However, most are of an atypical phenotype, positive
forThy 1 but negative forCD4 andCD8 (3, 4) . These "double
negative" T cells (DNTs) 1 also bear unusual markers, such
as Ly-6 (5), Ly24 (6), PCA (7), and H1.2F3 (8) . Despite their
1 Abbreviations used in this paper . BBS, borate buffered saline; BMC, bone
marrow cell ; B6, C57BL/6Byj; B6/lpr, C57BL/6-Ipr/lpr; B6/lpr-Igh=,
C57BL/6-lpr/lpr-Iglw/Igip ; DEA, diethanolamine; DNT, double negative
T cell; DTT, dithiothreitol; EDP, equivalent dilution factor; Igh,
immunoglobulin heavychain; MB/lpr, (MRL/lpr x B6/lpr)FI ; MRL/Ipr,
MRL/Mp-lpr/lpr; MRL/+, MRL/Mp-+ / + ; PNP, paranitrophenyl
phosphate ; SS, single-stranded; TNP-HSA, trinitrophenyl-human serum
albumin .
massively expanded numbers in vivo, these cells have been
surprisingly inert in vitro (9, 10) .
Since the T cells in lpr mice seem so obviously deranged,
this population has been the primary focus of a large body
ofresearch (11) . In vivo treatment with anti-T cell mAb (12)
or neonatal thymectomy (13-15) greatly diminished adeno-
pathy and autoantibody production, while thymectomy fol-
lowed by transplantation of a normal thymus reconstituted
disease (16) . More recently, we have demonstrated that the
characteristically abnormal T cells in lpr mice are intrinsi-
cally defective (17) . Lethally irradiated C57BL/6-lpr/lpr
(B6/lpr) mice reconstituted with equal amounts of bone
marrow from normal congenic mice (C57BL/6-Ly1 .1) and
from B6/lpr (Ly 1.2') mice developed massive lymphade-
nopathy as well as autoantibodies comparable in titer to mice
reconstituted with B6/lpr marrow alone. Strikingly, the
lymphadenopathy was due almost entirely to cells derived
from the 1pr marrow, indicating that normal T cells were
not undergoing abnormal differentiation in an lpr environment .
B cells from IF mice, in contrast, are not as obviously ab-
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older lpr mice hyperexpress Ia (18), but otherwise have no
known aberrant markers. Polyclonal activation at an earlyage
has been demonstrated (19), andBcell tolerancecanbe difficult
to induce (20, 21). TheC57BL/6-nu/nu,lpr/lpr strain develops
some autoantibodies in theabsence offunctional T cells(22),
suggesting that thelprB cell is intrinsicallyabnormal. Anti-
IgM treatment of B6/lpr mice depleted B cells, as expected,
but more interestingly, resulted in a moderate reduction in
adenopathy (23, 24) and a marked decrease in glomerulitis
(23). Recently, Perkins et al. (25) have shown that neonatal
MRIrMp-+/+ (MRL/+) mice engrafted with allotype-
congenic MRL/Mp-lpr/lpr-Igh° bone marrow preferentially
developed totalIgG2aandIgG2aanti-single stranded (ss)DNA
antibodies of donor lpr allotype. This occurred despite in-
direct evidence that most of the splenic B cells were of host
origin.
In thepresent work, we have tested critically whether au-
toantibody production in the Ipr model of SLE depends on
lpr-determined B cell abnormalities. Using congenic strains
on the B6 background, we have created double chimeras so
that normal and lpr B cells, marked by allotype, could de-
velop together in an lpr environment. Although the resul-
tant mice contained large numbers of both normal and lpr
B cells, they produced IgMand IgG2a autoantibodies almost
exclusively o£ the lpr donor allotype. Therefore, lpr B cells
areintrinsicallyprone to produce autoantibodies and are not
merely passive recipients of abnormal signals from aberrant
lpr T cells. Furthermore, the striking autoantibody produc-
tion of theIprmouse absolutely requires this intrinsic B cell
abnormality.
Materials and Methods
Mice. MRL/Mp-+/+ (MRL/+),MRL/Mp-Ipr/Ipr(MRL/
lpr), C57BL/6ByJ (B6), B6.C20 (B6-Igh'), C57BL/6-lpr/lpr
(B6/lpr), C57BL/6-lpr/lpr-Igh'/Igh' (B6/lpr-Igh'), and (MRL/Ipr
x B6/lpr)Fl were maintained in ourbreeding facility. TheMRL/
lpr, MRL/+, B6,andB6/lpr strainswere originally obtained from
TheJackson Laboratory (Bar Harbor, ME), and the B6.C20 was
obtained from GayleBosma(Institute forCancer Research,Philadel-
phia, PA). The B6/lpr-Igh' strain was developedin our laboratory
by crossing B6.C20 and B6/lpr. Homozygosity for Igh' and lpr
wastested at theF2 generation, andthe strain was established from
a single breeding pair. B6/lpr-Igh' characteristically develop sig-
nificant lymphadenopathy, splenomegaly, and autoantibodies to
chromatin and IgG by 5 mo-of-age.
Production ofDouble Chimeras.
￿
1 wk before cell transfer, 2-3-
mo-old mice were bled and transferred to autoclaved cages in an
isolation cubicle andprovided with neomycin (0.2% w/v)-treated
water. On theday ofbone marrow transfer, themice received 900
rad of y-radiation in a Gammacell 40 '3'Cs apparatus (Atomic
Energy of Canada, Ltd., Ottawa, Canada). Bone marrow cells
(BMCs) were prepared from the femurs and tibias of age- andsex-
matched congenic mice. After extensive washing in RPMI 1640
buffered with 15 mM HEPES and supplemented with penicillin
and streptomycin, BMCs were resuspended at 20 x 106/ml and
treatedwith saturating concentrations ofmonoclonal ratantiThy
1.2 (NEN Research Products, Boston, MA) for 30 min at 4°C,
washed again, andincubated with LowTox-M rabbit complement
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(Cedarlane Laboratories Limited, Ontario, Canada) for45 min at
37°C. For each donor group, equal numbers ofcells from the ap-
propriate suspensions were mixed together. In some cases, where
noted (see Results), B6/Ipr recipients were infused with ratios of
donor marrow favoring B6.C20 (+/+) over B6/lpr. Each mouse
received at least 10'BMCs by tail vein injection. Control mice re-
ceived no injection and died within 2 wk of irradiation.
Immunization of Chimeras with Thnitrophenyl--Human Serum Al-
bumin(TNPHSA~ Human serumalbuminwas trinitrophenylated
using2,4,6trinitrobenzenesulfonic acid (Eastman KodakCo., Roch-
ester, NY). Each mouse wasinjected subcutaneously with 0.1 mg
TNP-HSA in CFA (0.5 ml), followed, at 20-d intervals, by two
i.p. booster injections of 0.05 mg TNP-HSA in PBS. Mice were
bled midway between injections and 10 d after the second boost.
Enzyme-linked Immunosorbent Assay (ELISA)
Total Serum IgM andIgM".
￿
This assay is a modification of a
previously described protocol (26). Polyvinylchloride microtiter
plates (Dynatech Laboratories, Inc., Alexandria, VA)were coated
with 100 pl/wellof Bet 2, a non-allotype-specific rat anti-mouse
IgMmAb (27), at 1.5 itg/ml in borate buffered saline (BBS). The
plates were then washed in BBS and incubated with 200 Ed/well
of coating buffer (BBS, 0.5% BSA, 0.4% Tween 80, and 0.1%
NaN3) for at least 1 h. After aspiration, serum samples or stan-
dard positive sera diluted 1:2000 to 1:5000 in coating buffer were
added and allowed to bind overnight in the cold. Standard curves
for calibration of the assay consisted of two-fold serial dilutions
ofTEPC 183 (mouse IgM'; Organon Teknika, Durham, NC) and
CBPC 112 (mouse IgMb; [26]). The assaywas developed with bio-
tinylated HB100 (rat IgG1 anti-mouse IgM'; [27]) and AF6-
78.25.2 (mouse IgG1 anti-IgMb; [28]). In addition, standard
curves were compared to each other by development with bio-
tinylated Bet 2. Plates were then incubated with avidin-alkaline
phosphatase anddevelopedwith paranitrophenylphosphate(PNP;
Sigma Chemical Co., St. Louis, MO) at 1 mg/ml in 0.01 M
diethanolamine (DEA), pH 9.8. The plates were read on an auto-
matedELISAreader (Emax; MolecularDevicesCorporation, Menlo
Park, CA) at timed intervals. OD results were convertedto ug/ml
based on the concentration of TEPC 183.
TotalSerum IgG2a° and IgG2ak
￿
Microtiter plates were coated
with 100 Al/well affinity-purified goat anti-mouse Fab' (3 wg/ml)
in BBS as first step. Sera were diluted at 1:100,000 or 1:1,000,000
in coating buffer, and standard curves consistedof serial dilutions
of HB63 (IgG2a'; [26]) and CBPC 101 (IgG2ab; [26]). The plates
were washed, and previously standardized affinity-purified rabbit
anti-mouse IgG2a' or IgG2ab were added to replicateplates. Stan-
dard curves were also developedwith affinity-purified biotinylated
goat anti-mouse pFc' as an allotype nonspecific reagent. Theplates
were then treatedas above, andresultsareexpressedas pg/mlbased
on the concentration of HB63.
Total IgGl' and IgGlk
￿
This assay was performed as an
allotype-specific competitive inhibition ELISA. Microtiter plates
were coated with 20-9.10 (mAb anti-mouse IgGl'; [29]) or 412-
49.7.20 (mAb anti-mouse IgGlb; a gift of Dr. Fred Finkelman,
Uniformed Services University of the Health Sciences, Bethesda,
MD) at 3Ftg/ml (100 wl/well) in BBS. Afterwashing, plates were
incubated with 200 jA1/well of coating buffer. To inactivate IgM
rheumatoid factor, serum samples were reduced by being diluted
1:250 into 0.005 M dithiothreitol in BBS (BBS-DTT). Two-fold
serial dilutions of HB57 (mouse IgG1'; [26]) and MOPC 245
(mouse IgGlb; [26]) were also prepared in BBS-DTT After reduc-
tion for 1 h at room temperature, samples were alkylated with anequal volume of0.011M iodoacetamide in BBS. After 15 min, each
sample was divided into two equal aliquots, and an equal volume
of a 2 ug/ml solution ofeither HB57-alkaline phosphatase (HB57-
AP) or MOPC 245-alkaline phosphatase (MOPC 245AP) was
added . Those samples containing HB57-AP were added to plates
coated with 20-9-10 and those with MOPC 245-AP were added
to plates coated with 412-49 .7.20. After 2 h at 4°C, the plates were
washed and PNP substrate in DEA was added. Plates were read
at intervals as above . Standards and control sera of one allotype
could not inhibit the other in this assay.
Allotype-specific IgM and IgG2a Anti-Chromatin.
￿
These assays
paralleled those described above for allotype-specific totalIgM and
IgG2a, except that chromatin, purified from chicken erythrocyte
nuclei (30), was used as the first step (3 Rg/ml protein; 100 ul/well),
and samples were diluted 1:500 . Total immunoglobulin isotype levels
and anti-chromatin were generally determined in the same assay.
Results are reported based on the concentration ofTEPC 183 (for
IgM anti-chromatin) or HB63 (for IgG2a anti-chromatin) .
Allotype-specific IgM Anti-IgGl' and -IgG2b6 Rheumatoid Fac-
tor . Myeloma proteins HB57 (mouse IgGl') and BPC4 (mouse
IgG2bb) were absorbed with a Bet 2-Sepharose 4B gel to reduce
background, and used to coat microtiter plates at a concentration
of 3 ug/ml . After washing, plates were incubated with coating
buffer, followed by 1:500 dilutions of sera . Standard curves were
developed using serial dilutions of serum from reference B6/lpr and
B6/lpr-Igh' mice . Following overnight incubation, previously
standardized dilutions of biotinylated F(ab') Z fragments ofHB100
(anti-IgM') or AF6-78.25.2 (anti-IgMb) were added to replicate
plates. In addition, serial dilutions ofreference sera were also devel-
oped with biotinylated F(ab')2 fragments of Bet 2 to allow stan-
dardization to each other. The rest ofthe assay was handled as above,
except for data analysis, where results are reported in equivalent
dilution factors (EDF) . This is defined by the formula: EDF =
(Dilution of standard reference sera which gives the equivalentOD
of the test serum) x 106 (30) .
Immunofluorescence.
￿
Allotype-specific two-color IgD and IgM
immunofluorescence was routinely performed onPBMCs and selec-
tively on splenocytes to assess chimerism. Approximately 200 pl
of tail vein blood was collected into heparinized tubes, and
mononuclear cells were isolated using LympholyteM (Cedarlane,
Homby, Ontario) density gradients. White cells were collected into
buffered HBSS, supplemented with 3% FCS and 0.1% NaN3 . For
IgD staining, saturating amounts ofAF3-33.3.2 (IgG2a anti-IgDb ;
[28]) and biotinylated Hb'/1 (IgG2b anti-IgD' ; a generous gift of
Dr. F. Finkelman) were added for 30 min at 4° C . The second
step consisted ofincubation with saturating amounts offluorescei-
nated goat anti-mouse IgG2a (Southern Biotechnology Associates,
Birmingham, AL) and PE-coupled avidin (Southern Biotechnology
Associates) . The cells were washed three times in PBS and fixed
with an equal volume of2% paraformaldehyde in PBS . The IgM
protocol followed that for IgD except that AF6-78.25.2 (IgG1 anti-
IgMb) was used as the first step, followed, after washing, by
saturating amounts of fluoresceinated goat anti-mouse IgG1
(Southern Biotechnology Associates) . After more washing, more
AF6-78.25.2 was added to saturate any unoccupied second-step
binding sites . Biotinylated DSl (IgG1 anti-IgM'; [31]) was added
and followed, after washing, by PE-coupled avidin . In all cases,
B6.C20, B6, and (B6.C20 x B6)Fl PBLs were prepared concur-
rently as controls . Analysis wasperformed on an EpicsV flow cytom-
eter (Coulter Electronics Inc., Hialeah, FL) with size gating on
the lymphocyte population . Data were plotted on a three-decade
logarithmic scale . At least 5,000 events were collected for each
sample.
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Results
Initial Experiments in (MRL/lpr x B6/1pr)FI Chimeras
Suggested an Essential Role for the 1pr B Cell. Cohorts of
3-mo-old (MRL/Ipr x B6/lpr)Fl (MB/Ipr) mice were lethally
irradiated and reconstituted with five combinations ofT cell-
depleted bone marrow (4-5 mice per group) : I . MRL/+ &
136; II .MRL/lpr & 136 ; III . MRL/+ & B6/lpr ; IV MRL/lpr
& B6/lpr ; and V MB/Ipr. 4 mo after transfer, double
chimerism in Groups I-IV was verified by immunofluores-
cence ofPBMCs with mAbs to H-211(3-25.1) and H-2k (16-
1-2), both a gift ofDr. Jeff Frelinger (University of North
Carolina, Chapel Hill, NC) (32, 33) . Consistent with our
earlier results (17), the peripheral blood of mice from each
group showed substantial numbers of cells from each donor
type, although in Groups II and III, the IF cells predomi-
nated over the +/+ cells by an average ratio of 2:1. 6-7 mo
after transfer, the mice were sacrificed. Groups II-V had marked
lymphadenopathy, and the expanded populations mainly
expressed the aberrant DNT phenotype, Thy 1+ CD4-
CD8 - 9F3+, typical of 1pr T cells . Groups II and III had
a marked predominance ofcells of the Ipr vs +/+ phenotype
in the lymph nodes (80% vs 5%), but the thymus was equally
reconstituted, again in agreement with earlier results . Examina-
tion of splenic B cells showed I-Ab to IAk ratios similar to
those seen for H-2 expression in the peripheral blood (data
not shown) .
Serum total IgM and IgG2a levels were determined by
allotype-specific ELISA . Group II and III showed strong
skewing towards the allotype ofthe 1pr donor. All mice were
also tested for IgM rheumatoid factor, IgG2a anti-ssDNA,
and IgG2a anti-chromatin in allotype-specific ELISAs. In
Groups II and III, autoantibodies were mainly ofthe 1pr donor
allotype (data not shown) . These data suggested two alter-
native hypotheses : (a) The production of autoantibodies in
1pr mice may require expression of the 1pr gene in theB cells
themselves. (b) The Ipr T cells that may provide abnormal
help cannot cooperate effectively with nonsyngeneic B cells,
even though the T cells have differentiated in an F1 host .
To distinguish between thesetwo possibilities, we conducted
more extensive chimera experiments in histocompatible con-
genic strains of mice on the B6 background .
Double Chimerism in B6/lpr Recipients Was Achieved at the
Level ofPWpheralBlood Lymphocytes. 2-3-mo-old B6/lpr male
mice were lethally irradiated and reconstituted as double
chimeras with four combinations of T cell depleted bone
marrow : I. B6.C20 (Igh') & B6 (Ighb) ; II . B6/lpr-Igh' &
136; III. B6.C20 & B6/lpr ; and IV B6/lpr-Igh' & B6/lpr.
Chimerism was assessed at 5 mo after reconstitution using
two-color, allotype-specific IgD andIgM immunofluorescence
of peripheral blood B cells . The data for one of two similar
sets of experiments are summarized in the top half of Table
1 . Chimeras reconstituted withtwo normal (Group I) ortwo
IF marrows (Group IV) showed nearly equivalent numbers
ofbothIgM- and IgD-bearing cells derived from each donor .
Groups II and III, reconstituted with combinations of 1pr
and +/+ marrow, hadB cells ofboth donors, although the
1pr allotype tended to dominate.Table 1 .
￿
Allotype Distribution in B6/lpr and B6/lpr-Igha Double Chimeras
Serum autoantibody levels"
Immunofluorescence
￿
IgM RF specificity
of PBLs
￿
Serum immunoglobuhn'
￿
Anti-chromatin isotype
IgG1 IgG2bb
B6/lpr or B6/Ipr-Igha mice were lethally irradiated and given an equal number ofbone marrow cells ofeach allotype in four combinations : I . B6.C20
& B6 ; II . B6/lpr-Igha& B6; III . B6.C20 & B6/lpr; and IV . B6/lpr-Igha & B6/lpr. The data shown were obtained from mice bled 4 mo after recon-
stitution .
Geometric means .
t Igh allotype.
s Seven mice per group .
II Mean (SD) .
I Five mice per group, except for Group II, which had six .
Serum Ig in Double Chimeric Mice Came from both Bone
Marrow Donors. IgM, IgG2a, and IgG1 of the a and b allo-
types were detected in all double chimeric mice tested at 4
mo after reconstitution (Table 1) . In Groups II and III, the
lpr donor allotype (a and b, respectively) dominated in all
cases, particularly for IgG2a and IgG1 in Group III . In Groups
I and IV neither allotype was consistently favored, although
the b allotype was increased in the IgGl and IgG2a isotypes
in Group I .
Autoantibodies Were Derivedfrom lpr DonorMarrow.
￿
IgM
and IgG2a anti-chromatin autoantibody levels were determined
by allotype-specific ELISAs 4 mo after reconstitution (Table
1) . Strikingly, in Groups II and III, IgM and IgG2a anti-
chromatin autoantibodies were wholly of the lprdonor allo-
type. The double lpr chimeras in Group IV had substantial
amounts of anti-chromatin of both allotypes, while Group
I showed only very low levels ofb allotype autoantibody (prob-
ably due to recipient marrow recovery; see Discussion) .
Rheumatoid factors reactive with murine IgGla and
IgG2bb were also assayed (Table 1) . Again, autoantibodies
in mice of Groups II and III were derived entirely from the
lprdonorB cells . Trace levels ofrheumatoid factor were present
in Group I mice, while Group IV mice had RF of both al-
lotypes .
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Results Were Similar with B6/lpr--Igha Hosts.
￿
Parallel ex-
periments were performed with B6/lpr-Igh' recipients, and
data from one of two similar experiments are summarized
in the bottom halfofTable 1. Immunofluorescence ofPBMCs
again showed mixed chimerism, although Groups I and IV
showed some excess ofB cells of the a allotype. Serum total
IgM, IgG2a, and IgG1 were generally balanced in Groups
I and IV (except IgG2a in Group I), while these isotypes
were mostly skewed toward the lprdonor allotype in Groups
II and III . As in the B6/lpr-recipient chimeras, autoantibodies
in Groups II and III were entirely of the lpr donor allotype,
with the exception of a single Group III mouse, in which
there was some IgG2a' anti-chromatin in the presence of a
larger amount of IgG2ab anti-chromatin .
Double Chimeras Reconstituted with Excess Normal Marrow
Still Produced Autoantibodies Bearing Only the Allotype Derived
from the lprMarrow. An additional experiment was performed
in which B6/lpr mice were reconstituted at ratios 2:1, 5 :1,
and 10:1 ofB6.C20 to B6/lpr bone marrow in order to pro-
duce chimeras that favored the normal B cells. 1 mo after
reconstitution, peripheral bloodB cells were predominantly
of the normal a allotype, as shown by both IgD and IgM
immunofluorescence (data not shown) . Over the next 6 mo,
the percent of cells bearing the lprphenotype increased, par-
IgD
Group at bt
IgM
a b
IgM
a b
IgG2a
a b
IgG1
a b
IgM
a b a
IgG2a
b
(EDF)
a b
(EDF)
a b
(%) ('"g/ml) (!Ug/ml) (/Ug/ml) (fUg/ml) (ng/ml)
B6/lpr recipientss
I 17(3)1 21(5) 28(6) 11(2) 260 110 540 1,150 215 1,400 4 3 <5 14 3 <1 3 <2
II 18(7) 18(6) 32(5) 3(1) 1,800 110 3,200 570 980 280 95 2 1,005 7 20 <1 250 3
III 4(1) 24(5) 12(3) 21(5) 100 740 52 3,300 100 3,800 1 75 <5 7,000 3 31 3 71
N 10(2) 21(5) 21(3) 17(3) 720 300 1,690 1,670 825 2,200 24 15 500 1,200 16 8 35 28
B6/lpr-Igha recipientsi
I 24(9) 13(3) 35(6) 16(2) 532 233 1,430 80 490 700 <2 <1 100 <10 1 <0.5 6 <0.5
II 13(4) 6(2) 22(5) 7(1) 1,870 125 4,900 100 635 591 35 <1 2,300 10 30 <0.5 68 <0.5
III 6(2) 24(5) 15(5) 12(5) 240 2,100 993 1,200 604 2,000 3 30 190 1,750 3 22 3 33
IV 30(3) 21(5) 31(3) 14(3) 610 990 1,780 800 825 1,690 16 4 750 410 11 3 27 11m22 m23 m31 m32
Figure 1 .
￿
Allotype distribution ofsplenic B cells in unequally reconstitutedB6.C20& B6/lpr -+ B6/lpr Group III chimeras. 4 mo after reconstitution,
four mice were sacrificed and splenocytes examined by immunofluorescence. IgD, (/) . IgDb (®) . IgMa (®). IgMb (®) .
ticularly as detected by anti-IgM, although the normal B cell
predominance persisted in most cases. At 4 mo, four repre-
sentative mice were sacrificed, and their spleens were exam-
ined by immunofluorescence (Fig. 1) . The relative propor-
tions ofcells expressing the a and b allotypes were comparable
to that seen in peripheral blood and still favored the normal
a allotype.
Table 2 lists the serological data for individual mice 3-4
mo after reconstitution . In spite of the cellular bias towards
the normal +/+ B cells, total serumIgM was relatively evenly
balanced at this time. In contrast, serum total IgG2a and IgG1
were strongly biased towards the b allotype of the lpr donor.
Autoantibodies were detected in most dice and were derived
solely from the Ipr donor .
In Presence oflpr, Normal B Cells Showed Little Response to
Exogenous Antigen . To determine whether,the +/+ B cells
present in +/+-Ipr double chimeras were potentially func-
tional, approximately 7 mo after reconstitution, mice from
each of the four groupsshown in the top halfofTable 1 were
immunized withTNRHSA. Group I mice showed low preim-
munization levels of antiTNP antibody and a strong IgG2a
response of both allotypes (Fig. 2) . In contrast, lpr B cells
in Groups II, III and IV showed high preimmunization titers
of antiTNP, but had little additional response to immuniza-
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tion . +/+ B cells in Groups II and III had low preimmuni-
zation titers, but produced only a blunted response to an-
tigen . IgM antiTNP had a decreased but parallel response
(data not shown) . This experiment was repeated at an earlier
time following reconstitution (4 mo) using some ofthe B6/lpr
recipients given an excess of +/+ marrow, again with similar
results (data not shown) .
Discussion
The present results indicate that the production of anti-
bodies in the lpr model ofSLE requires expression of the lpr
gene in B cells. Preliminary experiments were performed by
transferring combinations ofMRL andB6 bonemarrow into
irradiated (MRL/Ipr x B6/lpr)F1 hosts. We confirmed our
earlier results demonstrating an intrinsic T cell abnormality
(17) . Surprisingly, autoantibodies appeared to be made pref-
erentially by cells from the lpr donor. Although this result
suggested that an Ipr-specific abnormality had to be expressed
in the B cells that produced autoantibodies, we could not
exclude the possibility that abnormal lprT cells preferentially
interacted with the syngeneic (i&, H-2 compatible) IprB cells.
We therefore performed additional experiments with chimeras
constructed using Igh-allotype congenic strains ofB6 mice.Table 2 .
￿
Allotype Distribution in Unequally Reconstituted Group III Mice
Immunofluorescence
￿
Anti-chromatin
￿
IgM RF specificity
of PBLs
￿
Serum immunoglobulin
￿
isotype
B6/lpr mice were lethally irradiated and given a combination of thy 1-treated bone marrow from B6.C20 and B6/lpr donors at the indicated ratios .
Mice were bled at monthly intervals . Immunofluorescence data are from 3 mo after reconstitution, while serologic data are from 3.5 to 4 mo .
" Ratio of B6.C20:B6/lpr donor marrow .
In these reconstituted mice, 1pr and +/+ B cells differed only
by Igh allotype. The results of five separate experiments in-
dicated that 1pr B cells were the sole source of autoantibodies,
despite the presence of +/+-derived cells as well .
To exclude the possibility of systematic assay errors and
to assess better the potential differences in autoantibody
production afforded by different Igh genes, both B6/lpr and
B6/lpr-Igh' hosts were tested . An additional possible con-
founding factor was host bone marrow recovery, despite le-
thal irradiation (34) :-In this regard, for B6/lpr hosts, data
from Group III, a mixture of B6.C20 and B6/lpr donor
marrow, allowed the clearest assessment of the contribution
ofB cells derived from infused normal marrow, since, in these
cases, host bonemarrow recovery could only add to the anti-
body bearing the 1pr donor allotype. Likewise, for B6/Ipr-
Igh' hosts, Group II, was the most critical . In both of these
groups, serum total IgM and IgG antibody were mainly of
the 1pr donor allotype, yetB cells and immunoglobulin from
the +/+ donor were clearly present . Nevertheless, autoanti-
bodies derived from normal donor cells were never seen, even
though anti-chromatin and rheumatoid factor ofthe Ipr allo-
type were usually present . Recipient bone marrow recovery
probably accounted for the increased amounts of b and a al-
lotype IgG in B6/lpr and B6/lpr-Igh', respectively, in
Group I of Table 1; for the low levels of autoantibody seen
in some Group I mice ; and for the single Group III B6/lpr-
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Igh' recipient which made appreciable levels of a allotype
IgG2a anti-chromatin . Finally, the crossover design of our
experiments also excluded the possibility that the preferen-
tial use oftheb allotype for autoantibody production, which
we have previously shown (35), could obscure the interpre-
tation of our results.
The ability to construct bona,fide +/+-1pr double chimeras
was critical to our approach. It has been reported that recon-
stitution of IF mice with a mixture of 1pr and +/+ marrow
results in complete takeover by 1prmarrow within 1mo (34),
although experience in our laboratory has been different (17) .
In the current work, recipients ofa 1:1 ratio of +/+ :lpr showed
a predominance of the Ipr-derived B cells in the peripheral
blood; however, +/+ B cells were always present in si
numbers (Table 1) . In those double chimeras reconstituted
with excess normal bone marrow, thenumber of +/+ pheno-
type B cells usually exceeded that of 1pr origin, in both the
peripheral blood and the spleen (Table 2) . In these same
animals, serum IgM was nearly balanced, while serum IgG2a
and IgG1 was dominated by the allotype derived from the
lpr donor. As in the donor-balanced chimeras, autoantibodies
of the IgM and IgG2a isotypes were entirely of 1pr origin .
Other work has suggested a role for cells not of bone
marrow origin in the development of 1pr lymphadenopathy
(36-38) . When lprbone marrow is introduced into a lethally
irradiated congenic +/+ mouse, a curious wasting syndrome
t
Mouse
number
IgD
a b
IgM
a b
IgM
a b
IgG2a
a b
IgGI
a b
IgM
a b
IgG2a
a b
IgGl
(EDF)
a b
IgG2bb
(EDF)
a b
M (!z8/ml) (#8/ml) (/, 1g/ml) (Izg/ml)
24 (2:1)' 7 5 12 5 100 450 100 1,740 <50 4,700 <1 46 <10 250 <1 <1 <1 14
29 (2:1) 33 12 5 5 570 590 80 1,130 70 5,500 <1 10 <10 <10 <1 10 <1 21
30 (2:1) 28 11 9 6 345 710 85 1,205 140 6,050 <1 5 <10 1,200 <1 8 <1 26
21 (5:1) 22 6 16 3 805 905 125 750 90 1,500 <1 15 <10 575 <1 54 <1 76
22 (5:1) 20 7 21 5 605 550 130 1,325 100 4,300 <1 36 <10 650 <1 18 <1 32
23 (5:1) 21 8 27 8 570 685 115 1,350 70 3,600 <1 9 <10 275 <1 10 <1 16
32 (5:1) 32 9 8 3 360 470 100 1,570 60 5,600 <1 67 <10 550 <1 6 <1 9
33 (5:1) 16 3 8 3 290 370 75 560 140 3,000 <1 35 <10 <10 <1 <1 <1 5
27 (10 :) 24 5 20 5 435 710 125 1,120 <50 4,100 <1 20 <10 350 <1 <1 <1 48
31 (10:1) 18 4 11 4 1,040 1,775 145 2,250 95 3,200 <1 6 <10 575 <1 16 <1 27
34 (10:1) 27 5 13 6 895 1,200 120 1,620 330 6,600 <1 6 <10 <10 <1 53 <1 55Figure 2 .
￿
IgG2a antiTNP response of chimeric mice . Mice were immunized subcutaneously with 100 Wg TNP-HSA in CPA and boosted twice
at 20-d intervals with 50 jig given intraperitoneally. IgG2a antiTNP antibodies were quantitated by allotype-specific ELISA . Pre-immunization levels
(open bars) and final titers 10 d after the last injection (closed bars) are shown for each group as geometric means .
ensues, leading to lymphoid depletion and early mortality
(39, 40) . If, however, an lpr lymph node is also transplanted,
these mice will develop adenopathy in that transplanted node
(38), suggesting that nonhemopoietic cellsmay be necessary
for full expression of the T cell defect . Perkins et al . (25)
have demonstrated that neonatal +/+ mice given lpr bone
marrow produce preferentially Ipr-allotype IgG2a and IgG2a
anti-ssDNA . These results indicated an intrinsic lpr B cell
defect, asshown in our current studies. Our present data ex-
tend these observations to show that a complete lpr environ-
ment, including the expanded population of lpr T cells, is
still not sufficient to stimulate normal B lymphocytes to se-
crete autoantibodies, thus indicating that the lprB cell is an
absolute requirement for autoantibody production in lpr mice.
An additional finding in the current study was that normal
lymphoid cells appeared to be immunosuppressed in an lpr
environment . This result parallels the impaired responses lpr
mice are known to have to exogenous antigens (41, 42) . In
double chimeric mice immunized with theT cell dependent
antigen, TNP-HSA, the normalB cells responded poorly in
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the presence of lpr donor marrow (Groups II and III ; Fig.
2) . This immunosuppression was not due to the non-bone-
marrow-derived lpr host environment, since lpr mice recon-
stituted with normal marrows (Group I) had a good IgG2a
response to TNP. Therefore, we assume that either the lpr
T cells or the lpr B cells exerted a strong downregulatory
effect in vivo. We are currently investigating the mechanism
of this suppression with further double chimera experiments .
The observed results cannot easily be explained by transfer
oflprB cells already committed to autoantibody production .
Autoantibodies did not become evident until at least 2 mo
after transfer. In addition, examination by immunofluores-
cence of bone marrow cells from lpr and normal mice failed
to show any appreciable staining for mouse K light chains
(data not shown) . Furthermore, allophenic mice, made by
the fusion of 1pr and normal embryos, also showed autoanti-
bodies only of the lpr phenotype (T Katagiri, S . Azuma, Y
Toyoda, S. Mori,K. Kano, P.L. Cohen, andR.A . Eisenberg,
manuscript in preparation) . The present study thus suggests
that either the lpr cells were specifically driven to IgG andautoantibody production or that the +/+ cells were inhibited
from doing so. In any case, the presence of the lprgene was
essential for the production of autoantibodies by theB cells .
The finding that lprB cells are intrinsicallyabnormal raises
questions as to the relative role of T cell andB cell defects
in the lpr model ofautoimmune disease. Although T cells
are clearly required for autoantibody production in lpr mice,
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